//
Lifestyle Modifications for Preventing and Treating Heart Failure
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT-HF study
Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
AIM2-driven inflammasome activation in heart failure
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)